Abstract:Stem Cells and DevelopmentVol. 24, No. 10 Letter to the EditorGene Targeting Through Homologous Recombination in Monkey Embryonic Stem Cells Using CRISPR/Cas9 SystemShengyun Zhu, Zhili Rong, Xiaofeng Lu, Yang Xu, and Xuemei FuShengyun ZhuShenzhen Children's Hospital, Shenzhen, Guangdong, China.Key Lab of Transplant Engineering and Immunology, Ministry of Health, West China Hospital, Sichuan University, Chengdu, China.Division of Biological Sciences, University of California, San Diego, La Jolla, California.Search for more papers by this author, Zhili RongDivision of Biological Sciences, University of California, San Diego, La Jolla, California.Cancer Research Institute, Southern Medical University, Guangzhou, Guangdong, China.Search for more papers by this author, Xiaofeng LuKey Lab of Transplant Engineering and Immunology, Ministry of Health, West China Hospital, Sichuan University, Chengdu, China.Search for more papers by this author, Yang XuDivision of Biological Sciences, University of California, San Diego, La Jolla, California.Search for more papers by this author, and Xuemei FuShenzhen Children's Hospital, Shenzhen, Guangdong, China.Search for more papers by this authorPublished Online:12 Jan 2015https://doi.org/10.1089/scd.2014.0507AboutSectionsView articleView Full TextSupplemental MaterialPDF/EPUBView Supplemental Data ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetailsCited BySingle‐strand annealing: Molecular mechanisms and potential applications in CRISPR‐Cas‐based precision genome editing10 December 2021 | Biotechnology Journal, Vol. 17, No. 7Application of CRISPR/Cas9 System in Establishing Large Animal Models17 May 2022 | Frontiers in Cell and Developmental Biology, Vol. 10Frontiers in Genetics, Vol. 11Robust and efficient knock-in in embryonic stem cells and early-stage embryos of the common marmoset using the CRISPR-Cas9 system6 February 2019 | Scientific Reports, Vol. 9, No. 1HIV-1 inhibition in cells with CXCR4 mutant genome created by CRISPR-Cas9 and piggyBac recombinant technologies5 June 2018 | Scientific Reports, Vol. 8, No. 1Efficient SSA ‐mediated precise genome editing using CRISPR /Cas925 August 2018 | The FEBS Journal, Vol. 285, No. 18Effects of clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated (Cas) protein 9 system-Based Deletion of miR-451 in Mouse Embryonic Stem Cells on Their Self-Renewal and Hematopoietic Differentiation8 March 2017 | Tissue Engineering and Regenerative Medicine, Vol. 14, No. 2Rhesus iPSC Safe Harbor Gene-Editing Platform for Stable Expression of Transgenes in Differentiated Cells of All Germ LayersMolecular Therapy, Vol. 25, No. 1 Volume 24Issue 10May 2015 InformationCopyright 2015, Mary Ann Liebert, Inc.To cite this article:Shengyun Zhu, Zhili Rong, Xiaofeng Lu, Yang Xu, and Xuemei Fu.Gene Targeting Through Homologous Recombination in Monkey Embryonic Stem Cells Using CRISPR/Cas9 System.Stem Cells and Development.May 2015.1147-1149.http://doi.org/10.1089/scd.2014.0507Online Ahead of Print:February 25, 2015Online Ahead of Editing: January 12, 2015Published in Volume: 24 Issue 10: January 12, 2015PDF download

Correction: Preclinical safety and biodistribution of CRISPR targeting SIV in non-human primates

Correction: Corrigendum: CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients

Correction: Corrigendum: Opportunities and challenges in modeling human brain disorders in transgenic primates

Gene Targeting Through Homologous Recombination in Monkey Embryonic Stem Cells Using CRISPR/Cas9 System

Generation of SIV-resistant T cells and macrophages from nonhuman primate induced pluripotent stem cells with edited CCR5 locus

Correction To: Therapeutic Efficacy, Pharmacokinetic Profiles, and Toxicological Activities of Humanized Antibody-Drug Conjugate Zt/g4-MMAE Targeting RON Receptor Tyrosine Kinase for Cancer Therapy

Prediction and validation of hematopoietic stem and progenitor cell off-target editing in transplanted rhesus macaques

Preclinical modeling highlights the therapeutic potential of hematopoietic stem cell gene editing for correction of SCID-X1

Corrigendum: Translatability of findings from cynomolgus monkey to human suggests a mechanistic role for IL-21 in promoting immunogenicity to an anti-PD-1/IL-21 mutein fusion protein

Correction: de Jesus et al. Voacanga globosa Spirobisindole Alkaloids Exert Antiviral Activity in HIV Latently Infected Cell Lines by Targeting the NF-κB Cascade: In Vitro and In Silico Investigations. Molecules 2022, 27, 1078

Differential impact of transplantation on peripheral and tissue-associated viral reservoirs: Implications for HIV gene therapy.

Erratum: Zeiser R, Blazar BR. Preclinical models of acute and chronic graft-versus-host disease: how predictive are they for a successful clinical translation? Blood. 2016;127(25):3117-3126

Updates on CRISPR-based gene editing in HIV-1/AIDS therapy

Corrigendum to 'CRISPR/Cas9 system and its applications in nervous system diseases' [Genes & Diseases 11 (2024) 675-686]

Correction: The Untranslated Regions of Classic Swine Fever Virus RNA Trigger Apoptosis

Generation of in situ CRISPR-mediated primary and metastatic cancer from monkey liver

Corrigendum to Biologic Treatment of 4 HIV-Positive Patients: A Case Series and Literature Review

CRISPR/Cas9 PIG -A gene editing in nonhuman primate model demonstrates no intrinsic clonal expansion of PNH HSPCs.

Correction: Musumeci et al. Intranasal Administration of a TRAIL Neutralizing Monoclonal Antibody Adsorbed in PLGA Nanoparticles and NLC Nanosystems: An In Vivo Study on a Mouse Model of Alzheimer's Disease. Biomedicines 2022, 10, 985

Whole genome sequencing of CCR5 CRISPR-Cas9-edited Mauritian cynomolgus macaque blastomeres reveals large-scale deletions and off-target edits

Erratum: A CRISPR Interference of CBP and p300 Selectively Induced Synthetic Lethality in Bladder Cancer Cells In Vitro: Erratum.